Approved Products

S. No. Product Form Strength Therapeutic category US EU CA AUS
1 Atorvastatin Tablets 10mg, 20mg, 40mg, 80mg Anti-Hypertensive
2 Carbamazepine ER Tablets 100mg, 200mg, 400mg Anti- Convulsant
3 Carbamazepine IR Tablets 100mg, 200mg, 400mg Anti- Convulsant ✓ (100,200)
4 Celecoxib Capsules 50mg, 100mg, 200mg, 400mg NSAIDs
5 Chlorthalidone Tablets 25mg, 50mg Thiazide - diuretic
6 Deferasirox Tablets 90mg, 180mg, 360mg Iron Chelator
7 Diclofenac Potassium Tablets 50mg NSAIDs
8 Olmesartan Tablets 5mg, 20mg, 40mg Anti-Hypertensive ✓ (20,40)
9 Olmesartan + HCTZ Tablets 20mg + 12.5mg, 40mg + 12.5mg, 40mg + 25mg Anti-Hypertensive
10 Pirfenidone Tablets 267mg, 801mg Idiopathic Pulmonary Fibrosis
11 Ranolazine PR Tablets 375mg, 500mg, 750mg Anti - Angina
12 Rosuvastatin Tablets 5mg, 10mg, 20mg, 40mg Anti - hyperlipidemic
13 Sildenafil Tablets 25mg, 50mg, 100mg Erectile Dysfunction
(50,100)
14 Sildenafil Tablets 20mg Anti-Hypertensive
15 Solifenacin Tablets 5mg, 10mg Overactive Bladder
16 Tadalafil Tablets 2.5mg, 5mg, 10mg, 20mg Anti-Hypertensive
We have several products in the pipeline. Please get in touch for further enquiries at pratik.kothari@umedicalabs.com or rahul.chavan@umedicalabs.com

Disclaimer:
Information relating to any active pharmaceutical ingredient (API) and/or products on this Site (collectively the “Products”) is provided by Umedica Laboratories for general information purposes only. The Product information herein is not intended to provide complete medical information. Products covered by valid patents in any country are not offered or supplied for commercial use; Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1). The patent position of the product should be verified by the buyer. Product information outlined herein should not be construed as a promotion or solicitation for any Product or service or for the use of any Product or service that is not authorized by the laws and regulations of India.